Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, and inflammatory diseases such as rheumatoid arthritis, gout and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and lasts for up to…
Community, Culture, Applications & Research
Explore the main themes, entities and connections around Naproxen. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
risk nsaids effects gastrointestinal available pain sodium anti-inflammatory use brand nsaid drug disease united name ulcers pregnancy mg bleeding may
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Naproxen | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Naproxen | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Naproxen | ATC code | G02CC02 (WHO) M01AE02 (WHO), M02AA12 (WHO), M01AE56 (WHO), M01AE52 (WHO) | 1.00 | infobox |
| Naproxen | Bioavailability | 100% (by mouth) | 1.00 | infobox |
| Naproxen | CAS Number | 22204-53-1 Y | 1.00 | infobox |
| Naproxen | ChEBI | CHEBI:7476 Y | 1.00 | infobox |
| Naproxen | ChEMBL | ChEMBL154 Y | 1.00 | infobox |
| Naproxen | ChemSpider | 137720 Y | 1.00 | infobox |
| Naproxen | CompTox Dashboard (EPA) | DTXSID4040686 | 1.00 | infobox |
| Naproxen | DrugBank | DB00788 Y | 1.00 | infobox |
| Naproxen | Duration of action | 12 hours | 1.00 | infobox |
| Naproxen | ECHA InfoCard | 100.040.747 | 1.00 | infobox |
| Naproxen | Elimination half-life | 14 hours (adults) | 1.00 | infobox |
| Naproxen | Excretion | Kidney | 1.00 | infobox |
| Naproxen | Formula | C14H14O3 | 1.00 | infobox |
| Naproxen | KEGG | D00118 Y | 1.00 | infobox |
| Naproxen | KEGG | as salt: D00970 Y | 1.00 | infobox |
| Naproxen | Legal status | AU: S2 (Pharmacy medicine) when in preparations that contain no more than 15 days' supply. Otherwise it is Schedule 4 (Prescription only). | 1.00 | infobox |
| Naproxen | Legal status | CA: OTC / Rx-only | 1.00 | infobox |
| Naproxen | Legal status | UK: POM (Prescription only) / P | 1.00 | infobox |
| Naproxen | Legal status | US: OTC / Rx-only | 1.00 | infobox |
| Naproxen | License data | US DailyMed: Naproxen | 1.00 | infobox |
| Naproxen | MedlinePlus | a681029 | 1.00 | infobox |
| Naproxen | Melting point | 152–154 °C (306–309 °F) | 1.00 | infobox |
| Naproxen | Metabolism | Liver (to 6-desmethylnaproxen) | 1.00 | infobox |
| Naproxen | Molar mass | 230.263 g·mol−1 | 1.00 | infobox |
| Naproxen | Onset of action | 1 hour | 1.00 | infobox |
| Naproxen | PDB ligand | NPX (PDBe, RCSB PDB) | 1.00 | infobox |
| Naproxen | Pregnancy category | AU: C | 1.00 | infobox |
| Naproxen | Pronunciation | /nəˈprɒksən/ | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.